Food and Drug Administration has approved an oral formulation of semaglutide for a new drug or biologic under the ...

In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...

Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

A daily weight-loss pill will soon be available in the US, after the regulator gave approval to Danish drug company Novo ...

The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

GLP-1 receptor agonists have captured global attention for their ability to drive weight loss and improve metabolic health.

Obesity treatment can include GLP-1 medications, non-surgical procedures such as ESG stomach tightening and short-term gastric balloons, and traditional bariatric surgery. Here’s an alarming fact: 42% ...

“Early intervention would be lifestyle change, and that can be extremely helpful, especially in younger adolescents who are ...

Extra body weight and too little activity are now among the top drivers of cancer. To keep cancer rates low in Utah, we need ...

Obesity has traditionally been considered a risk factor for various diseases. However, it is increasingly recognized as a disease by medical societies and governments. The 2020 Canadian Adult Obesity ...